Figure 1.
The clinical course after the initiation of nivolumab. After switching to ipilimumab, acute hyperglycemia and the development of F1DM were seen. The commencement of intensive insulin therapy improved the plasma glucose levels.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.